Let's see what is said about Feinstein - this is the interesting part for me. Notice how GK hesitated about the clinical timeframe for Cantrixil - I reckon we will get an update on Tuesday which will be earlier. IMO of course.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint